A selection of major announcements

1. Guangzhou Automobile Group: The sales volume of new energy vehicles in August was about 49,500 units, an increase of 62.68% over the previous year

$GAC GROUP (02238.HK)$According to the announcement, the automobile sales volume in August was 196,800 units, down 9.68% year on year, and the cumulative sales volume for this year was 1,557,700 units, down 2.34% year on year. Among them, sales volume of new energy vehicles in August was 49,500 units, up 62.68% year on year; cumulative sales volume this year was 335,900 units, up 96.64% year on year.

2. Alibaba: Will continue to implement Alibaba Cloud's spin-off listing plan

$Alibaba (BABA.US)$The Group issued a voluntary announcement on the Hong Kong Stock Exchange announcing the completion of the leadership handover. Mr. Choi Sung-shin will take over as the chairman of the company's board of directors and Mr. Wu Yongming will take over as the company's CEO and director. Additionally, Alibaba announced that Mr. Wu Yongming will succeed Mr. Zhang Yong as the acting chairman and CEO of Alibaba Cloud Intelligence Group. The appointment will take effect on September 10, 2023.

Alibaba will continue to implement the previously announced plan to split Alibaba Cloud Intelligence Group and appoint a separate management team for it. The completion of the spin-off plan depends on a variety of factors, including, but not limited to, the successful restructuring of assets, liabilities, and contracts, implementation of equity incentive plans, market conditions, and regulatory approvals in relevant jurisdictions.

3. Baolong Real Estate: Contract sales in August were 2,067 billion yuan, down 23.7% year on year

$POWERLONG (01238.HK)$It was announced that contract sales for August this year were 2,067 billion yuan (RMB, same below), a year-on-year decrease of 23.7%; the contract sales area was 141,200 square meters, a year-on-year decrease of 23.49%. The cumulative contract sales volume for the eight months ended August 31, 2023 was RMB 21,708 billion, a year-on-year decrease of 25.55%; the total cumulative contract sales area was 1,413,900 square meters, a year-on-year decrease of 27.11%.

4. Junshi Biotech plans to use a joint venture as a financing platform to introduce external funding to accelerate research and development of research projects in the field of cancer treatment

$JUNSHI BIO (01877.HK)$It was announced that in order to accelerate the research and development of the company's ongoing research projects, the company, Shanghai Junshi Bioengineering Co., Ltd. (“Junshi Engineering”), a wholly-owned subsidiary of the company, Suzhou Junmeng Biomedical Technology Co., Ltd. (“Suzhou Junmeng”) and the company's non-executive director, intend to sign a “joint venture agreement” with Shanghai Anlingke Biomedical Co., Ltd. (“Joint Venture”) and Feng Hui, a non-executive director of the company. The company plans to invest 2 assets and some patent rights (“underlying intangible assets”) of 2 ongoing research projects (in the field of tumor treatment) in the pre-clinical research and development stage (“underlying intangible assets”) Sign up for a joint venture The company added RMB 140,000 to its registered capital, and the rest was included in the joint venture capital reserve (“this capital increase”).

5. Nuocheng Jianhua: Plans to use HK$200 million to buy back Hong Kong shares on the market

$INNOCARE (09969.HK)$It was announced that on September 8, 2023, the board of directors of the company approved the use of HK$200 million on the market to repurchase shares of companies listed on the main board of the Hong Kong Stock Exchange Limited. The share repurchase plan is based on the confidence of the company's management team, the company's current business growth prospects and financial situation, and also takes into account recent market conditions and macroeconomic performance indicators. The company intends to fund the share repurchase plan with its own financial resources rather than proceeds from the listing of shares on the main board of the Hong Kong Stock Exchange Limited.

Operational data

$GAC GROUP (02238.HK)$: In August, sales of new energy vehicles were about 49,500 units, an increase of 62.68% over the previous year

$POWERLONG (01238.HK)$: Contract sales in August were 2,067 billion yuan, down 23.7% year on year

$CHINA SUNTIEN (00956.HK)$: The amount of electricity generated completed in August was 632,700 megawatt-hours, a year-on-year decrease of 20.99%

Investment and operation

$BABA-SW (09988.HK)$Alibaba Cloud Intelligence Group Announces Changes in Chairman and CEO

$CHALCO (02600.HK)$: Affiliated Yunlu Co., Ltd. plans to sell 100,000 tons of electrolytic aluminum production capacity target to Qinghai branch for 602 million yuan

$CITIC SEC (06030.HK)$: Jinshi Investment plans to invest 500 million yuan to participate in the Anhui Hailuo Jinshi Innovation and Development Fund

$GUOLIAN SEC (01456.HK)$: Approved by the China Securities Regulatory Commission to establish a wholly-owned asset management subsidiary

$CAPITAL ENV (03989.HK)$: The subsidiary plans to acquire all shares of Xinjiang Tianfu waste incineration power generation for 120 million yuan

$CIRC (01763.HK)$: It is proposed to sell 100% of the shares of Beijing North Biotechnology Research Institute Co., Ltd. by listing on the Beijing Equity Exchange

$JUNSHI BIO (01877.HK)$It is proposed to use a joint venture as a financing platform to introduce external funds to accelerate research and development of research projects in the field of cancer treatment

$FOSUN PHARMA (02196.HK)$: Guilin Southern Pharmaceutical was approved as the marketing license holder for paramivir injection

$UNITED LAB (03933.HK)$: The group product TUL01101 tablets obtained implied permission for clinical trials

$CHENMING PAPER (01812.HK)$It is proposed to sell 65.21% of Wuhan Chenming's shares for 480 million yuan

Repurchase cancellation

$INNOCARE (09969.HK)$: It is proposed to use HK$200 million to buy back Hong Kong shares on the market

$HSBC HOLDINGS (00005.HK)$On September 7, it spent approximately HK$160 million to repurchase 2,7887,900 shares

$BEKE-W (02423.HK)$On September 8, it cost about 1.5 million US dollars to repurchase about 268,300 shares

$YUM CHINA (09987.HK)$On September 7, it spent about 1.5 million dollars to buy back 29,000 shares

$SINOPEC CORP (00386.HK)$On September 8, 32.688 million shares were cancelled and shares already repurchased

edit/new